Trial Profile
A Phase II Trial of Xeloda [capecitabine], Every Three Week Taxol [Paclitaxel] and Herceptin in Metastatic Breast Cancer
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Paclitaxel; Trastuzumab
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 30 Sep 2005 New trial record.